Fox Chase Cancer Center /ID# 239372 — Philadelphia, Pennsylvania

Fox Chase Cancer Center /ID# 239372 is a clinical research site located in Philadelphia, Pennsylvania, United States 19111.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Fox Chase Cancer Center /ID# 239372 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Acute Myeloid Leukemia (AML).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fox Chase Cancer Center /ID# 239372?

Fox Chase Cancer Center /ID# 239372 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fox Chase Cancer Center /ID# 239372 conducted?

Fox Chase Cancer Center /ID# 239372 has 1 clinical trials on record, with 1 currently active. Their work covers Acute Myeloid Leukemia (AML).

Is Fox Chase Cancer Center /ID# 239372 accredited by Crixeo Health?

Fox Chase Cancer Center /ID# 239372 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fox Chase Cancer Center /ID# 239372?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.